文献速递主动脉疾病

融合影像在肾下腹主动脉瘤修复中的前瞻性观察试验

A prospective observational trial of fusion imaging in infrarenal aneurysms.
PubMed 文献 · J Vasc Surg · 2018-05-24

本前瞻性观察试验纳入2016年3月至2017年4月在本中心接受EVAR的44例患者,与2015年3月至2016年3月21例回顾性对照比较,评估Cydar融合软件在杂交手术室和移动C臂上对肾下腹主动脉瘤修复的辐射剂量影响。结果显示融合组空气比释动能显著低于对照组(82 vs 142 mGy,P=0.03),数字减影血管造影次数显著减少(8 vs 10,P=0.03),剂量面积乘积无显著差异(P=0.10),总体辐射剂量降低约50%。

要点

  • 融合影像在肾下腹主动脉瘤EVAR中可行,杂交手术室和移动C臂均可使用。
  • 融合组空气比释动能显著低于对照组(82 vs 142 mGy,P=0.03)。
  • 融合组DSA次数显著少于对照组(8 vs 10,P=0.03),总体辐射剂量降低约50%。

核心结论

  • 在肾下腹主动脉瘤修复这类简单手术中,基于影像的融合技术在杂交手术室和移动系统上均可行,并使总体辐射剂量降低约50%。
  • 作者认为,融合技术应成为力求最大程度降低辐射剂量的中心的标准治疗,即使无法进行杂交手术室的资本投入。

研究设计与样本

  • 前瞻性观察试验,纳入2016年3月至2017年4月在本中心接受EVAR并同意参与试验的所有患者44例,与2015年3月至2016年3月在同一中心接受治疗的21例回顾性对照患者比较。
  • 排除破裂动脉瘤和复杂EVAR;融合组入组前对所有操作者进行了辐射防护和Cydar融合软件使用的教学培训。
  • 记录术前和围手术期特征,包括空气比释动能和剂量面积乘积等辐射剂量参数,结果以中位数和四分位距表示。

主要发现

  • 融合组与对照组在性别、体重指数和修复时年龄方面无显著差异。
  • 中位手术时间(wire to wire)为90(75-105)分钟,中位透视时间为30(22-34)分钟,组间无显著差异(P=0.56和P=0.36)。
  • 剂量面积乘积对照组为21.7(8.9-85.9)Gy cm2,融合组为12.4(7.5-23.4)Gy cm2,对照组较高但未达统计学显著(P=0.10)。
  • 空气比释动能对照组为142(61-541)mGy,显著高于融合组的82(51-115)mGy(P=0.03)。
  • 数字减影血管造影次数融合组为8(6-11),显著低于对照组的10(9-14)(P=0.03);不良事件、内漏或需额外手术的频率组间无显著差异。

临床怎么用

  • 作者认为,融合技术应成为力求最大程度降低辐射剂量的中心的标准治疗,即使无法进行杂交手术室的资本投入。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Use of three-dimensional fusion has been shown to significantly reduce radiation exposure and contrast material use in complex (fenestrated and branched) endovascular aneurysm repair (EVAR). Cydar software (CYDAR Medical, Cambridge, United Kingdom) is a cloud-based technology that can provide imaging guidance by overlaying preoperative three-dimensional vessel anatomy from computed tomography scans onto live fluoroscopy images both in hybrid operating rooms and on mobile C-arms. The aim of this study was to determine whether radiation dose reduction would occur with the addition of fusion imaging to infrarenal repair in all imaging environments. METHODS: All patients who consented to involvement in the trial and who were treated with EVAR in our center from March 2016 until April 2017 were included. A teaching session about radiation protection and Cydar fusion software use was provided to all operators before the start of the fusion group enrollment. This group was compared with a retrospective cohort of patients treated in the same center from March 2015 to March 2016, after a dedicated program of radiation awareness and reduction was introduced. Ruptured aneurysms and complex EVAR were excluded. Preoperative and perioperative characteristics were recorded, including parameters of radiation dose, such as air kerma and dose-area product. Results were expressed in median and interquartile range. RESULTS: Forty-four patients were prospectively enrolled and compared with 21 retrospective control patients. No significant differences were found in comparing sex, body mass index, and age at repair. The median operation time (wire to wire) and fluoroscopy time were 90 (75-105) minutes and 30 (22-34) minutes, respectively, without significant differences between groups (P = .56 and P = .36). Dose-area product was nonsignificantly higher in the control group, 21.7 (8.9-85.9) Gy cm2, compared with the fusion group, 12.4 (7.5-23.4) Gy cm2 (P = .10). Air kerma product was significantly higher in the control group, 142 (61-541) mGy, compared with 82 (51-115) mGy in the fusion group (P = .03). The number of digital subtraction angiography runs was significantly lower in the fusion group (8 [6-11]) compared with the control group (10 [9-14]); (P = .03). There were no significant differences in the frequency of adverse events, endoleaks, or additional procedures required. CONCLUSIONS: When it is used in simple procedures such as infrarenal aneurysm repair, image-based fusion technology is feasible both in hybrid operating rooms and on mobile systems and leads to an overall 50% reduction in radiation dose. Fusion technology should become standard of care for centers attempting to maximize radiation dose reduction, even if capital investment of a hybrid operating room is not feasible.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Maurel B, Martin-Gonzalez T, Chong D, et al. A prospective observational trial of fusion imaging in infrarenal aneurysms. J Vasc Surg. 2018. PMID: 29804734. doi:10.1016/j.jvs.2018.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。